VADIM GUSHCHIN, MD

Plain English
This study looked at how the temperature during a specific cancer treatment (cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy, or CRS/HIPEC) affects patient survival. Researchers found that patients who maintained a temperature of at least 40.5°C for at least 70% of the procedure had a median survival of 149.4 months, compared to 80.3 months for those who didn’t meet these conditions. This shows that keeping the right temperature can significantly improve outcomes for patients undergoing this treatment. Who this helps: This helps cancer patients undergoing CRS/HIPEC.

Plain English
This study examined the variety of HIV-1 strains and the level of drug resistance in the Donetsk, Luhansk, and Zaporizhzhia regions. Researchers analyzed 392 HIV genetic sequences and found that 3.6% of patients showed mutations that made their virus resistant to common treatments, with specific high levels of resistance noted for certain drugs. Understanding the genetic diversity and resistance patterns of HIV in this area is important for better treatment strategies and patient care. Who this helps: Patients living with HIV in these regions.

Plain English
This study looked at the financial strain that patients experience after undergoing a specific type of cancer treatment called cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Researchers found that 31% of patients faced significant financial issues, which were linked to a lower quality of life, particularly among those who had additional chemotherapy, were single, or identified as part of racial and ethnic minority groups. Over time, however, financial strain tends to improve, with patients reporting better financial well-being by one year after treatment. Who this helps: This research benefits cancer patients and their families by highlighting the financial challenges they may face and how those challenges evolve after treatment.

Plain English
This study looked at bacteria found in the milk of Yakutian cattle suffering from mastitis, an infection that can harm the cows and impact milk production. Researchers identified five types of these bacteria using advanced genetic sequencing techniques. They found that all the bacteria were resistant to multiple antibiotics, with one type showing the strongest resistance to nearly all tested antibiotics except one, which is concerning for treatment options. Who this helps: This helps veterinarians and cattle farmers in managing and treating mastitis in cattle.

Plain English
Researchers studied a rare and aggressive type of appendix cancer called goblet cell adenocarcinoma (GCA) to better understand its treatment using a method called CRS/HIPEC, which combines surgery and heated chemotherapy. Out of 183 patients, 30 had no spread of cancer, while 153 had peritoneal disease; among those with peritoneal disease, nearly 62.7% saw cancer return after treatment, and their five-year survival rate was 29.5%. This research highlights that while CRS/HIPEC can be beneficial for certain GCA patients, especially those without metastasis, more work is needed to help doctors determine which patients will benefit most. Who this helps: This helps patients diagnosed with goblet cell adenocarcinoma of the appendix.

Plain English
This study focused on two types of surgical techniques for treating cancers on the surface of the abdominal cavity in women. The researchers demonstrated both a complete surgery that removes the entire pelvic area (classic pelvic peritonectomy) and a modified version that preserves some organs (visceral-sparing pelvic peritonectomy). Mastering these techniques is important because it increases the chances of successfully removing tumors in complex cases. Who this helps: This helps female patients with peritoneal surface malignancies.

Plain English
This study focused on the relationship between certain bacteria and pseudomyxoma peritonei (PMP), a type of cancer. Researchers analyzed microbial communities in 70 PMP tumors and found consistent groups of bacteria across samples, including those that may come from surgical contamination and others linked to colorectal cancer. They also discovered that chemotherapy before surgery tends to lower the diversity of these microbes. This research is important because it improves how we understand the microbes found in tumors, which could influence cancer treatment and outcomes. Who this helps: This helps patients with pseudomyxoma peritonei and colorectal cancer, as well as their doctors.

Plain English
This study looked at how a marker of inflammation in the blood, called C-reactive protein (CRP), relates to survival in patients with mucinous appendix cancer (MAC) who were treated with a specific type of surgery and chemotherapy. The researchers found that in patients with low-grade MAC, those who had a CRP level of 2.00 mg/dL or higher had significantly worse outcomes: only 53.9% were alive without disease progression after five years, compared to 88.5% for those with lower CRP levels. This is important because it suggests that measuring CRP levels before treatment could help doctors predict which patients might have worse outcomes and who could benefit from additional therapies. Who this helps: Patients with mucinous appendix cancer and their doctors.

Plain English
This study looked at how delays in starting chemotherapy after surgery and a special treatment called HIPEC affect the survival of women with advanced ovarian cancer. Researchers found that nearly half of the 95 patients experienced delays of 60 days or more, but overall, starting chemotherapy late did not significantly impact survival rates for most patients once other health factors were taken into account. However, for some patients with specific conditions, early chemotherapy appeared to worsen survival. Who this helps: This information helps doctors make better decisions for treating older ovarian cancer patients with high tumor burden after surgery.

Plain English
This study looked at patients with mucinous appendix cancer who needed treatment at specialized centers known for their expertise. It found that those traveling from out-of-state took longer to present for treatment, had more advanced cancer, and had more prior treatments compared to in-state patients, but their chances for successful surgery and survival were similar. This matters because it highlights the importance of early referrals for patients who need specialized care, ensuring they get timely treatment despite traveling long distances. Who this helps: Patients with mucinous appendix cancer needing specialized treatment.

Plain English
This study looked at a specific surgical technique called left lateral liver lobectomy (LLLL) used during surgery to remove cancerous lesions from the liver for patients with low-grade appendiceal mucinous neoplasm (LAMN). The researchers found that LLLL enabled complete removal of difficult-to-reach tumors, and after two years, the patient showed no symptoms or signs of disease. This is important because successfully removing these tumors can improve outcomes for patients with extensive cancer spread. Who this helps: This helps patients with low-grade appendiceal cancer and doctors performing complex surgeries.

Plain English
This study looked at how previous surgeries affect the outcomes of patients with mucinous appendix cancer who undergo a special treatment called CRS/HIPEC. It found that 63% of the 351 patients had fewer prior surgeries, leading to better overall survival rates (76% vs. 66% over five years) compared to those who had multiple surgeries. The research suggests that women are more likely to undergo more extensive surgeries, which can delay treatment and increase complications, emphasizing the need for careful surgical decisions. Who this helps: This helps patients with mucinous appendix cancer and their doctors.

Plain English
This study looked at how two types of treatments for ovarian cancer—cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) versus surgery alone—affect the likelihood of small bowel obstruction (SBO) and the amount of time patients stay free from obstruction. The research found that only 24.1% of patients who had CRS/HIPEC experienced SBO, compared to 42.0% of those who had surgery alone. Additionally, patients who received CRS/HIPEC had a median obstruction-free survival of 42.9 months, compared to 20.0 months for the other group, which is a significant improvement. Who this helps: This benefits ovarian cancer patients by potentially reducing complications and extending their quality of life.

Plain English
This study looked at the best ways to monitor patients with mucinous appendix cancer (MAC) after they have had surgery and chemotherapy. Researchers analyzed data from 385 patients and found that the likelihood of cancer coming back varies depending on the type of cancer and the time after treatment. For example, during the first 16 months, the recurrence risk was higher—up to 3.8 cases per 10 person-years for certain types—while it dropped significantly in later periods. This research leads to better monitoring schedules tailored to each type of MAC, which is important for early detection and treatment. Who this helps: This benefits patients with mucinous appendix cancer by improving how often they are checked for recurrence.

Plain English
This study looked at the genetic differences of HIV-1 in the Far Eastern Federal District of Russia from 2022 to 2024 to help improve strategies for fighting the virus, including vaccine development. Researchers found that 72.15% of the samples were a specific variant (A6), while other variants made up smaller portions: CRF63 at 10.13%, and so on. They also noted that 55.7% of samples had mutations linked to drug resistance, with the most common mutations found in 43.04% and 13.92% of cases, respectively. This research is important because it provides key information for developing better vaccines and treatment options for HIV. Who this helps: This helps patients living with HIV and healthcare providers working on treatment and prevention strategies.

Plain English
This study focused on understanding how many lymph nodes (LNs) need to be examined in patients with appendix cancer to accurately assess their condition. Researchers found that examining at least ten lymph nodes is essential; only examining fewer than ten was linked to a higher likelihood of missing cancer spread, affecting survival rates. Specifically, patients who were not evaluated for at least ten lymph nodes had a 39% higher risk of worse outcomes. Who this helps: This research benefits patients with appendix cancer and their doctors by guiding more effective staging and treatment decisions.

Plain English
This study looked at how surgical and gynecological oncologists worked together to treat advanced ovarian cancer, which often spreads significantly within the abdomen. Out of 199 patients, 95% of those with primary cancer and 91% with recurrent cancer had all visible cancer removed during surgery. The results showed that patients had a median overall survival of 68 months for primary cancer and 50 months for recurrent cancer, indicating that this teamwork can lead to better outcomes even when the cancer is advanced. Who this helps: This benefits patients with advanced epithelial ovarian cancer and their healthcare providers.

Plain English
This study looked at how effective a type of cancer treatment called CRS/HIPEC is in lower-middle-income countries, using Ukraine as an example. Researchers examined the outcomes of 596 patients with different types of cancer and found that most had high rates of successful surgery—for instance, 84% of patients in Kyiv with appendiceal cancer had good surgical outcomes. This is important because it shows that it's possible to provide high-quality cancer care even in resource-limited settings. Who this helps: This helps cancer patients in lower-middle-income countries.

Plain English
This study looked at the effectiveness of a combination treatment called cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for patients with rare forms of ovarian cancer that had spread within the abdominal cavity. Out of 44 patients, 28 received the treatment, and 96.4% achieved minimal remaining cancer after surgery. The study found that 68.5% of patients survived for five years after treatment, which highlights that this approach can be a viable option for managing these challenging cases. Who this helps: This benefits patients with rare ovarian cancer and their doctors by providing new treatment options.

Plain English
This study looked at the quality of life of cancer survivors who underwent a specific surgery and treatment called CRS/HIPEC. Researchers interviewed eight patients and found that traditional quality of life questionnaires did not cover many of their unique experiences, particularly regarding physical symptoms, mental health, and the overall process of recovery. They developed 22 new questions that address these specific challenges, highlighting the need for more tailored assessments for this patient group. Who this helps: This helps cancer survivors undergoing CRS/HIPEC and the doctors treating them.

Plain English
This study looked at how different appearances of peritoneal cancer (cancer in the lining of the abdomen) seen during surgery relate to actual disease confirmed by lab tests. Researchers analyzed data from 707 patients and found that cancer nodules had a high confirmation rate of 63.1% compared to 31.5% for less severe lesions. This is important because understanding these variations can improve surgical decisions and patient outcomes. Who this helps: Patients with peritoneal cancer and their doctors.

Plain English
This study examined HIV infection trends in Crimea from 2014 to 2023. Researchers found that while fewer new HIV cases were reported, the total number of people living with HIV increased, with 81% of patients achieving low viral loads by 2023. It also noted that more infections occurred through heterosexual contact rather than drug use, and patients are getting older when diagnosed. Who this helps: This benefits patients and healthcare providers working to manage and treat HIV in Crimea.

Plain English
This study looked at whether adding chemotherapy after surgery could help patients with high-grade appendiceal cancer live longer. Researchers found that among 180 patients, those who received additional chemotherapy had a median survival of 53 months, compared to 75 months for those who didn't receive chemotherapy, but the difference was not significant. This raises questions about whether chemotherapy is effective for this type of cancer and suggests the need for more research, particularly since the tumor biology might differ from other cancers. Who this helps: This information benefits doctors and researchers working with patients who have high-grade appendiceal cancer.

Plain English
This study looked at the safety of kidney removal (nephrectomy) during a type of cancer treatment called cytoreductive surgery combined with heated chemotherapy (CRS/HIPEC). Out of 828 patients, 13 underwent nephrectomy while the rest did not, and results showed that both groups had similar rates of severe complications and death. This matters because it supports the idea that nephrectomy can be safely performed during this treatment without increasing risks or delaying follow-up chemotherapy. Who this helps: This helps cancer patients who may need kidney removal during their treatment.

Plain English
This study looked at the outcomes of patients with advanced ovarian carcinosarcoma, a rare and aggressive cancer, who received a combination of surgery and heated chemotherapy. Out of 267 patients with tubo-ovarian cancers, 20 had this specific type of cancer, and 16 of them underwent surgery followed by chemotherapy. The results showed that most patients (93.7%) had successful tumor removal, with a median survival time of about 21 months after treatment. Who this helps: This helps patients with advanced ovarian carcinosarcoma and their doctors by providing insights into effective treatment options.

Plain English
Researchers created a new vaccine candidate by combining parts of the yellow fever vaccine and the tick-borne encephalitis virus (TBEV). This new chimera virus effectively replicates in mammalian cells and prompts the immune system to produce antibodies against TBEV in mice. Importantly, it is capable of infecting the nervous system at certain doses, which raises concerns about its safety as a vaccine. Who this helps: This benefits researchers and vaccine developers working to prevent tick-borne encephalitis.

Plain English
Researchers developed a new test that quickly identifies multiple respiratory viruses, including SARS-CoV-2, influenza A, respiratory syncytial virus, and adenovirus, all within 17 minutes. This test uses a technology called surface-enhanced Raman spectroscopy (SERS), which detects viruses based on how they change signals from specially designed markers. This advancement is important because it offers a faster, reliable way to diagnose illnesses, which is crucial during outbreaks and pandemics. Who this helps: This benefits patients and healthcare providers by enabling quicker diagnosis of viral infections.

Plain English
This study looked at two patients with late-stage breast cancer that had spread to the abdominal area, which is difficult to treat. Both patients underwent a procedure called cytoreductive surgery combined with heated chemotherapy, known as CRS/HIPEC, after previous treatments didn't work. The first patient experienced a cancer recurrence after 26 months, while the second patient had no recurrence and lived for 38 months before dying from cancer that spread outside the abdominal area. This matters because it shows that CRS/HIPEC can be a safe and effective option for some patients whose standard treatments have failed. Who this helps: This helps patients with metastatic breast cancer and their doctors by providing a potential new treatment option.

Plain English
This study looked at how different types of appendix cancer come back after treatment with surgery and heated chemotherapy. Researchers found that about 34% of patients had a recurrence after an average of 78 months. They noticed that low-grade cancers mostly returned in the same area (16%), while high-grade types had higher rates of recurrence in other parts of the body (27% for high-grade cancer and 36% for signet ring cell cancers). The findings help doctors understand how to manage follow-up care and treatment for patients based on their specific type of cancer. Who this helps: This research benefits patients with appendix cancer and the doctors who treat them.

Plain English
This study looked at trends in HIV infection rates in Russia from 2011 to 2022, focusing on how many people were getting tested, how many were receiving treatment, and the rates of mortality linked to HIV. It found that while new HIV infections are decreasing, the total number of people living with HIV is rising, with treatment success rates remaining fairly high, between 72% and 77%. Understanding these trends is important for effectively managing and preventing HIV spread in different regions of the country. Who this helps: This benefits patients living with HIV and healthcare providers involved in treatment and prevention efforts.

Plain English
This study looked at how well repeated surgeries combined with heated chemotherapy (called iterative CRS/HIPEC) work for patients with recurring mucinous adenocarcinoma of the appendix, a type of cancer. The researchers found that patients who underwent these repeated procedures had a median survival of 80.2 months, compared to just 36.2 months for similar patients who didn't have the repeated treatments. This is important because it shows that some patients with lower and higher-grade tumors can significantly benefit from these additional surgeries, though it doesn't seem helpful for those with a specific tumor type known as signet-ring cell carcinoma. Who this helps: This research benefits patients with recurrent appendiceal cancer who are eligible for additional surgeries.

Plain English
The study looked at how strong the immune response (measured as "avidity") of IgG antibodies to a part of the SARS-CoV-2 virus relates to the severity of COVID-19 reinfections among patients. It found that patients who were reinfected but had mild cases displayed much stronger immune responses (82.3% average avidity) compared to those with initial infections (37.1%). Conversely, reinfected patients with severe cases had low immune responses with no significant difference from those who were primarily infected. This information is important because it indicates that low antibody avidity during reinfection significantly increases the risk of severe COVID-19. Who this helps: This helps patients and doctors understand the risk of severe COVID-19 reinfection based on immune response.

Plain English
This paper reviews the role of bacteria in a rare condition called pseudomyxoma peritonei (PMP), which starts in the appendix and causes harmful growths in the abdomen. Researchers found that while some studies suggest bacteria might influence the progression of this disease, there isn't enough solid evidence yet to support using antibacterial treatments. This matters because patients with PMP often face severe symptoms and limited treatment options, highlighting the need for more research to understand the disease better. Who this helps: This helps patients with pseudomyxoma peritonei and their doctors by identifying areas for future research that could improve treatment options.

Plain English
This study focused on how to deactivate bovine coronaviruses (BCoVs), which harm cattle’s digestive and respiratory systems, using a method called photodynamic inactivation. Researchers treated the viruses with certain light-sensitive chemicals and then exposed them to red light, resulting in a reduction of viral particles by at least 10,000 times. These findings are significant because they suggest a new way to combat virus infections in cattle, which could help improve livestock health and farming productivity. Who this helps: This helps farmers and veterinarians working with cattle.

Plain English
This study looked at patients with high-grade mucinous appendiceal cancer who couldn't have surgery after a failed attempt to remove their tumors. It found that those who received systemic chemotherapy lived longer, with a median survival of 26 months compared to just 12 months for those who did not get chemotherapy. This is important because it shows that systemic chemotherapy can significantly improve survival for patients in this difficult situation. Who this helps: Patients with high-grade mucinous appendiceal cancer and their doctors.

Plain English
This study focused on creating a new tool that can quickly and accurately detect the SARS-CoV-2 virus in bodily fluids. The researchers developed a sensor that can identify very small amounts of the virus, finding it in concentrations as low as 100 copies per milliliter, which is as sensitive as current top diagnostic tests. This technology is important because it can lead to faster diagnosis and better management of COVID-19. Who this helps: This helps patients and healthcare providers involved in diagnosing and treating COVID-19.

Plain English
This study looked at the different types of hepatitis B virus (HBV) found in various native groups in Siberia by analyzing 381 DNA sequences from these populations. The researchers discovered that specific HBV types were predominant in different groups, with subgenotype D1 found in 100% of Altaian Kazakhs, Tuvans, and Teleuts, while D2 was most common among the Nenets, Komi, and Khants at 71%. These findings show that these groups likely contracted HBV from different sources, highlighting the importance of understanding the virus's spread in isolated populations. Who this helps: This research helps public health officials and healthcare providers working with Siberian native populations.